ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Juvenile idiopathic arthritis (JIA) and ultrasound"

  • Abstract Number: 62 • 2017 Pediatric Rheumatology Symposium

    Novel Approach to Quantifying Joint Pathology Via Musculoskeletal Ultrasound in Newly Diagnosed Juvenile Idiopathic Arthritis

    Leandra Woolnough1, David Wilkes2, Yassine Kanaan2, Tracey Wright3 and Heather Benham4, 1UT Southwestern Medical Center, DALLAS, TX, 2Texas Scottish Rite Hospital for Children, Dallas, TX, 3Pediatrics/Rheumatology, UT Southwestern Medical Center, Dallas, TX, 4Pediatric Rheumatology, Texas Scottish Rite Hospital for Children, Dallas, TX

    Background/Purpose:  The pathology of inflammation in Juvenile Idiopathic Arthritis (JIA), including thickening and vascularization of the synovial membrane, joint effusion and bony erosions, can be…
  • Abstract Number: 2023 • 2012 ACR/ARHP Annual Meeting

    Should Joint Ultrasound Contribute to Therapeutic Decisions in Juvenile Idiopathic Arthritis?

    Marie Halbwachs1, Geraldine Durand2, Caroline Robin1, Catherine Gambert Abdel Rahman1, Pierre Ingrand3 and Elisabeth Solau-Gervais2, 1Paediatric, University Hospital, Poitiers, France, 2Rheumatology, University Hospital, Poitiers, France, 3Inserm, CIC-P 802, University Hospital, Poitiers, France

    Background/Purpose: Over several years, numerous studies have been published on the interest of joint ultrasound in juvenile idiopathic arthritis. Several authors have demonstrated that ultrasonography…
  • Abstract Number: 1167 • 2012 ACR/ARHP Annual Meeting

    Golimumab in 25 Young Adults Affected by Juvenile Idiopathic ARTHRITIS NON Responders to OTHER Biological Agents: Preliminary DATA

    Irene Pontikaki1, Orazio De Lucia2, Maurizio Gattinara3, Alessandra Salmaso1, Pier Luigi Meroni4 and Valeria Gerloni1, 1Pediatric Rheumatology, Orthopedic Institute Gaetano Pini, Milano, Italy, 2Rheumatology, Orthopedic Institute Gaetano Pini, Milano, Italy, 3Pediatric Rheumatology, Istituto Ortopedico Gaetano Pini, Milano, Italy, 4Division of Rheumatology, Istituto G. Pini, University of Milan, Milano, Italy

    Background/Purpose: Biological agents licensed in JIA have demonstrated a favourable benefit-to-risk profile. Nevertheless, intolerance, loss and lack of efficacy or adverse events have led to…
  • Abstract Number: 122 • 2012 ACR/ARHP Annual Meeting

    Grey-Scale Ultrasonography with Power Doppler Technique: An Available Tool for the Assessment of Subclinical Joint Inflammatory Activity in Juvenile Idiopathic Arthritis

    Paz Collado1, Rosa Merino2, J. Graña Sr.3, Sagrario Bustabad-Reyes4, MariLuz Gamir5, Mari Luz García6 and Inmaculada Calvo7, 1Rheumatology, Severo Ochoa University Hospital, Madrid, Spain, 2Hospital Universitario La Paz, Madrid, Spain, 3Hospital Juan Canalejo, Spain, 4Rheumatology, Hospital Universitario de Canarias, La Laguna. Tenerife, Spain, 5Rheumatology, Ramon y Cajal University Hospital, Madrid, Spain, 6Hospital de Basurto, Bilbao, Spain, 7Hospital de La Fe, Valencia, Spain

    Background/Purpose: To investigate the usefulness of ultrasonography with power Doppler (PDUS) in detecting synovitis compared with clinical examination on large number of joints in JIA.…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology